Christine Cheneau

652 total citations
10 papers, 100 citations indexed

About

Christine Cheneau is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Christine Cheneau has authored 10 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Virology and 3 papers in Emergency Medicine. Recurrent topics in Christine Cheneau's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (7 papers) and HIV/AIDS Research and Interventions (7 papers). Christine Cheneau is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (7 papers) and HIV/AIDS Research and Interventions (7 papers). Christine Cheneau collaborates with scholars based in France, United States and Canada. Christine Cheneau's co-authors include David Rey, Marialuisa Partisani, Jean-Marie Lang, Marie‐Paule Schmitt, Jean Sibilia, Pierre Gantner, Rose‐Marie Javier, Geneviève Beck-Wirth, J Faller and Bruno Spire and has published in prestigious journals such as PLoS ONE, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Christine Cheneau

10 papers receiving 97 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine Cheneau France	7	77	52	29	29	13	10	100
Pere Domingo Pedrol Spain	6	45 0.6×	22 0.4×	24 0.8×	22 0.8×	5 0.4×	10	65
Anne Simon France	6	103 1.3×	95 1.8×	33 1.1×	35 1.2×		6	151
Anita Scribner United States	6	203 2.6×	156 3.0×	48 1.7×	62 2.1×	9 0.7×	7	245
Hylke Waalewijn Netherlands	4	79 1.0×	41 0.8×	37 1.3×	30 1.0×	2 0.2×	10	116
Cédrick Wallet France	6	177 2.3×	158 3.0×	45 1.6×	102 3.5×	26 2.0×	9	242
Olivier Leleux France	7	52 0.7×	22 0.4×	44 1.5×	44 1.5×	2 0.2×	14	97
S Zaheri Netherlands	3	55 0.7×	27 0.5×	45 1.6×	22 0.8×		4	79
Jordi Casabona Spain	5	37 0.5×	26 0.5×	24 0.8×	17 0.6×		9	64
Ainoa Ugarte Spain	6	86 1.1×	58 1.1×	29 1.0×	36 1.2×		21	117
Arianna Emiliozzi Italy	5	52 0.7×	44 0.8×	14 0.5×	23 0.8×	5 0.4×	8	72

Countries citing papers authored by Christine Cheneau

Since Specialization

Citations

This map shows the geographic impact of Christine Cheneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Cheneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Cheneau more than expected).

Fields of papers citing papers by Christine Cheneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Cheneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Cheneau. The network helps show where Christine Cheneau may publish in the future.

Co-authorship network of co-authors of Christine Cheneau

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Cheneau. A scholar is included among the top collaborators of Christine Cheneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Cheneau. Christine Cheneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Gantner, Pierre, Cindy Barnig, Marialuisa Partisani, et al.. (2018). Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing. AIDS. 32(7). 921–926. 4 indexed citations

2.

Gantner, Pierre, Guinevere Q. Lee, David Rey, et al.. (2017). Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs. Journal of Antimicrobial Chemotherapy. 73(4). 1045–1053. 7 indexed citations

3.

Gantner, Pierre, et al.. (2015). Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center. PLoS ONE. 10(12). e0145440–e0145440. 9 indexed citations

4.

Rey, David, et al.. (2014). Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART. Infectious Diseases. 47(2). 88–95. 16 indexed citations

5.

Gantner, Pierre, Marialuisa Partisani, Christine Cheneau, et al.. (2014). Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study. Scandinavian Journal of Infectious Diseases. 46(12). 838–845. 6 indexed citations

6.

Protopopescu, Camélia, Bruno Spire, C. Michelet, et al.. (2014). Twelve-Year Mortality in HIV-Infected Patients Receiving Antiretroviral Therapy: The Role of Social Vulnerability. The ANRS CO8 APROCO-COPILOTE cohort. Antiviral Therapy. 20(7). 763–772. 7 indexed citations

7.

Rey, David, et al.. (2006). Virologic Response of Zidovudine, Lamivudine, and Tenofovir Disoproxil Fumarate Combination in Antiretroviral-Naive HIV-1-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(5). 530–534. 14 indexed citations

8.

Rey, David, et al.. (2004). Tolerance of a Short Course of Nevirapine, Associated With 2 Nucleoside Analogues, in Postexposure Prophylaxis of HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(4). 1454–1456. 10 indexed citations

9.

Rey, David, et al.. (2001). Efavirenz as a Substitute for Protease Inhibitors in HIV-1–Infected Patients With Undetectable Plasma Viral Load on HAART: A Median Follow-Up of 64 Weeks. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(5). 459–462. 21 indexed citations

10.

Rey, David, et al.. (2001). Efavirenz as a Substitute for Protease Inhibitors in HIV-1–Infected Patients With Undetectable Plasma Viral Load on HAART: A Median Follow-Up of 64 Weeks. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(5). 459–462. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact